Who
Jan Malcolm
Director
Company insider
Files Form 4 as: Director, United Therapeutics.
In numbers
- Trades disclosed
- 35
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $977K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 26 Jun 2024
- Last trade
- 22 Jul 2026
- Last filed
- 23 Jul 2026
Companies traded
Activity over time
1 Sep 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —380 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,190 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —380 at $0.00 | filing |
| 22 Jul 2026filed 23 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,190 at $0.00 | filing |
| 10 Jul 2026filed 10 Jul 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $179K325 at $550.59 | filing |
| 10 Jul 2026filed 10 Jul 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $179K325 at $550.59 | filing |
| 9 Jul 2026filed 10 Jul 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | —650 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —650 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | UTHR United Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —650 at $0.00 | filing |
| 9 Jul 2026filed 10 Jul 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Code M | —650 at $0.00 | filing |
| 17 Mar 2026filed 17 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $24K45 at $533.51 | filing |
| 17 Mar 2026filed 17 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $24K45 at $533.51 | filing |
| 3 Mar 2026filed 3 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $25K50 at $509.20 | filing |
| 3 Mar 2026filed 3 Mar 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $25K50 at $509.20 | filing |
| 17 Feb 2026filed 17 Feb 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $24K50 at $474.68 | filing |
| 17 Feb 2026filed 17 Feb 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $24K50 at $474.68 | filing |
| 3 Feb 2026filed 3 Feb 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $24K50 at $474.23 | filing |
| 3 Feb 2026filed 3 Feb 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $24K50 at $474.23 | filing |
| 16 Jan 2026filed 20 Jan 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $23K50 at $460.98 | filing |
| 16 Jan 2026filed 20 Jan 2026 | UTHR United TherapeuticsBiotechnology | SEC FORM 4 Sold | $23K50 at $460.98 | filing |
News
Share Repurchase Plan Announced by United Therapeutics (NASDAQ:UTHR) Board of DirectorsUTHR · tickerreport.com · 23 Oct 2026United Therapeutics (NASDAQ:UTHR) Price Target Raised to $725.00UTHR · dailypolitical.com · 22 Oct 2026Contrasting Xenon Pharmaceuticals (NASDAQ:XENE) and United Therapeutics (NASDAQ:UTHR)UTHR · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Jan Malcolm; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.